Hartwell named inaugural fellow of cancer research association
Posted April 19, 2013
Leland “Lee” Hartwell is one of two Arizona State University faculty members among an elite group of scientists selected into the first class of Fellows of the American Association for Cancer Research.
Hartwell, a winner of the Nobel Prize in Medicine or Physiology for his pioneering work on genes that control cell growth and division, and their links to cancer, is a professor in the School of Biological and Health Systems Engineering, one of ASU’s Ira A. Fulton Schools of Engineering.
In 2009, Hartwell was recruited to ASU as the Virginia G. Piper Chair of Personalized Medicine, and chief scientist at the Center for Sustainable Health at ASU’s Biodesign Institute. The center’s mission is to sustain health through the integration of molecular and behavioral metrics, to improve health outcomes while reducing its costs, and to advance science education. At the center, he continues his focus on molecular diagnostics and the establishment of a Global Biosignatures Network.
He will be joined in the group of Fellows of the American Association for Cancer Research by ASU’s Raymond “Ray” Dubois. He is an internationally renowned expert who has explored the links between inflammation and cancer, particularly, the molecular and genetic basis of colon cancer and development of therapeutics to help in the prevention of colorectal cancer.
In 2012, DuBois was named the executive director of ASU’s Biodesign Institute and holds joint appointments as the Dalton Chair, School of Health Solutions and professor in the Department of Chemistry and Biochemistry. His appointment includes co-leadership of the Cancer Prevention Program at the Mayo Clinic, where he plays a key role in realizing the potential of accelerating an active partnership between ASU and the Mayo Clinic.
“Drs. Hartwell and DuBois have made indelible contributions to changing our worldview of cancer research and the development of new paradigms and the way we think about the progression, treatment, and ultimately, prevention of cancer,” said ASU President Michael Crow.